Molecular Mechanisms of Shigella Pathogenesis; Recent Advances.
Wolfram Manuel BrückWolfram Manuel BrückThomas Bartholomäus BrückPublished in: International journal of molecular sciences (2023)
Shigella species are the main cause of bacillary diarrhoea or shigellosis in humans. These organisms are the inhabitants of the human intestinal tract; however, they are one of the main concerns in public health in both developed and developing countries. In this study, we reviewed and summarised the previous studies and recent advances in molecular mechanisms of pathogenesis of Shigella Dysenteriae and non-Dysenteriae species. Regarding the molecular mechanisms of pathogenesis and the presence of virulence factor encoding genes in Shigella strains, species of this bacteria are categorised into Dysenteriae and non-Dysenteriae clinical groups. Shigella species uses attachment, invasion, intracellular motility, toxin secretion and host cell interruption mechanisms, causing mild diarrhoea, haemorrhagic colitis and haemolytic uremic syndrome diseases in humans through the expression of effector delivery systems, protein effectors, toxins, host cell immune system evasion and iron uptake genes. The investigation of these genes and molecular mechanisms can help us to develop and design new methods to detect and differentiate these organisms in food and clinical samples and determine appropriate strategies to prevent and treat the intestinal and extraintestinal infections caused by these enteric pathogens.
Keyphrases
- public health
- escherichia coli
- genome wide
- gram negative
- cell therapy
- endothelial cells
- pseudomonas aeruginosa
- antimicrobial resistance
- genome wide identification
- biofilm formation
- irritable bowel syndrome
- dendritic cells
- staphylococcus aureus
- stem cells
- cystic fibrosis
- gene expression
- cell migration
- immune response
- case report
- binding protein
- dna methylation
- climate change
- induced pluripotent stem cells
- genome wide analysis
- protein protein
- candida albicans
- ulcerative colitis